Cargando…
Advantages of Azithromycin Over Erythromycin in Improving the Gastric Emptying Half-Time in Adult Patients With Gastroparesis
BACKGROUND/AIMS: Current therapy for gastroparesis with prokinetic agents is limited by options and side effects. One macrolide, erythromycin (ERY), is associated with possible sudden cardiac death from QT prolongation due to P450 iso-enzyme inhibition. An alternative, azithromycin (AZI), lacks P450...
Autores principales: | Larson, Jean M, Tavakkoli, Anna, Drane, Walter E, Toskes, Phillip P, Moshiree, Baharak |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Neurogastroenterology and Motility
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978393/ https://www.ncbi.nlm.nih.gov/pubmed/21103422 http://dx.doi.org/10.5056/jnm.2010.16.4.407 |
Ejemplares similares
-
Influence of Gastric Emptying and Gut Transit Testing on Clinical Management Decisions in Suspected Gastroparesis
por: Hasler, William L., et al.
Publicado: (2019) -
Glass half empty? Lessons learned about gastroparesis
por: McKenzie, Patrick, et al.
Publicado: (2018) -
Reprogramming of Gastric Motility with “Pulse Therapy” (Metoclopramide and Erythromycin) in Severe Gastroparesis
por: Shah, Shamik, et al.
Publicado: (2013) -
Evaluation of gastric emptying in patients with gastroparesis by three-dimensional ultrasound
por: Shi, Jinjun, et al.
Publicado: (2021) -
Assessment of the Prevalence of Diabetic Gastroparesis and Validation of Gastric Emptying Scintigraphy for Diagnosis
por: Alipour, Zeinab, et al.
Publicado: (2017)